Beating Cystic Fibrosis

In the 1970s, most children with CF never made it through elementary school. Today the median life expectancy for the 30,000 Americans living with cystic fibrosis is closing in on 40, and expected to increase.
Emily Schaller is one of the estimated 30,000 Americans living with cystic fibrosis. (Cystic Fibrosis Foundation)

It started out like any other day for Emily Schaller. A good hair day, even. And then, there it was: a single gray hair.

Plucking the hair and others that soon followed was more than just humbling rite of passage for Schaller. On the cusp of turning 30, it meant that she had, for the time being, beat the odds stacked against her since she was diagnosed with cystic fibrosis (CF) as an infant.

“If not dying young means I have a full head of gray, I’ll take it,” said Schaller.

Schaller, now 31, is among the estimated 30,000 Americans who are living with CF, a fatal genetic disease that gums up the lungs with unusually thick, sticky mucus, leading to serious respiratory infections. The repeated infections cause decreased lung function, lung damage, and, eventually, lung failure. The mucus also clogs the pancreas, so the body cannot properly digest or absorb food, leading to malnutrition.

CF is caused by inheriting a mutated CFTR gene (and the errant protein it produces) from each parent. Normally, the healthy CF gene makes a protein that is found in the cells that line various organs. This protein controls the movement of chloride and sodium (components of salt) in and out of these cells. In people with CF, the protein is defective, causing the salt balance in the body to be disturbed. Because there is too little salt and water on the outside of the cells, the thin layer of mucus that helps keep the lungs free of germs becomes very thick and difficult to move.

In the 1970s, most children with CF never made it through elementary school. By the early 1980s, when Schaller was diagnosed at 18 months old, children with CF were not expected to live beyond their eighteenth birthday. Though some people with CF still succumb to the disease as a child or young adult, the median life expectancy of someone with CF is closing in on 40 years old—a figure that is expected to increase.

Like most adults living with CF, Schaller admits she grew up thinking she would not live as long as her classmates. But with the development of new drugs and airway clearance techniques that are helping to make cystic fibrosis a manageable disease, she’s a drummer, a triathlete, and the CEO of Rock CF, a Denver-based non-profit organization aimed at improving quality of life for people with CF through exercise.

Having outlived her prognosis, she has found herself navigating new territory was wasn't necessarily prepared for. “I worry about things I really never thought I’d have to think about—like health insurance and having an income to support myself and my parents getting older.”

“CF has really transformed from a childhood disease to one in which adults are planning and living out their futures,” said Seth Walker, a pulmonologist who heads up the Adult Cystic Fibrosis Center at Emory University at Atlanta. He estimates that more than half of the CF patients treated at Emory are adults.

That shift stems largely from the introduction of new strategies to manage the disease. One approach is chest therapy that clears the airways of mucous before it has time to block the airways. Breathing treatments that thin mucous and powerful antibiotics that prevent or control infection are others. And taking pancreatic enzymes can help the body absorb fat and protein. Schaller relies on all three, in addition to a rigorous physical conditioning, to keep the disease in check.

She also is one of a small number of CF patients who are on Kalydeco, the first FDA-approved drug to target the underlying cause of CF—a rare mutation in the CF gene called G551D-CFTR—rather than symptom management. Kalydeco, developed by Vertex Pharmaceuticals in Cambridge, Massachusetts, was designed to correct the function of the defective protein made by the CF gene. It allows chloride and sodium to move properly in and out of cells lining the lungs and other organs.

Jump to comments
Presented by

Aimee Swartz is a freelance writer based in Washington, D.C. Her work has appeared in The Washington Post and The Scientist.

Get Today's Top Stories in Your Inbox (preview)

A Technicolor Time-Lapse of Alaska's Northern Lights

The beauty of aurora borealis, as seen from America's last frontier

Join the Discussion

After you comment, click Post. If you’re not already logged in you will be asked to log in or register. blog comments powered by Disqus


What Do You Wish You Learned in College?

Ivy League academics reveal their undergrad regrets


Famous Movies, Reimagined

From Apocalypse Now to The Lord of the Rings, this clever video puts a new spin on Hollywood's greatest hits.


What Is a City?

Cities are like nothing else on Earth.


CrossFit Versus Yoga: Choose a Side

How a workout becomes a social identity


In Online Dating, Everyone's a Little Bit Racist

The co-founder of OKCupid shares findings from his analysis of millions of users' data.



More in Health

Just In